Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression

Oncogene

Volumn 25, Issue 6, 2006, Pages 888-898

  Heckman, C A ^a,b   Duan, H ^a,b   Garcia, P B ^a,b   Boxer, L M ^a,b  

^a Ctr for Molec Biology in Medicine   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bcl 2; Bob 1; Lymphoma; Oct; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN; PROTEIN BCL 2; PROTEIN BOB 1; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BINDING SITE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

APOPTOSIS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CELL SURVIVAL; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LYMPHOMA; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; OCTAMER TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; REGULATORY SEQUENCES, NUCLEIC ACID; TRANS-ACTIVATORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 32544459290     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209127     Document Type: Article

References (53)

1. Annweiler A, Zwilling S, Wirth T. (1994). Nucl Acids Res 22: 4250-4258.
2. Bendall HH, Scherer DC, Edson CR, Ballard DW, Oltz EM. (1997). J Biol Chem 272: 28826-28828.
3. Bertolino E, Singh H. (2002). Mol Cell 10: 397-407.
4. Brunner C, Marinkovic D, Klein J, Samardzic T, Nitschke L, Wirth T. (2003). J Exp Med 197: 1205-1211.
5. Chen H-M, Boxer LM. (1995). Mol Cell Biol 15: 3840-3847.
6. Corcoran LM, Karvelas M, Nossal GJ, Ye ZS, Jacks T, Baltimore D. (1993). Genes Dev 7: 570-582.
7. Dunn TL, Ross IL, Hume DA. (1996). Blood 88: 4072-4073.
8. Frampton J, Ramqvist T, Graf T. (1996). Genes Dev 10: 2720-2731.
9. Grassilli E, Salomoni P, Perrotti D, Franceschi C, Calabretta B. (1999). Cancer Res 59: 2451-2456.
10. Greiner A, Muller KB, Hess J, Pfeffer K, Muller-Hermelink HK, Wirth T. (2000). Am J Pathol 150: 501-507.
11. Grenfell SJ, Latchman DS, Thomas NS. (1996). Biochem J 315: 889-893.
12. Hatada EN, Chen-Kiang S, Scheidereit C. (2000). Eur J Immunol 30: 174-184.
13. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG. (1989). Nature 340: 35-41.
14. Heckman C, Mochon E, Arcinas M, Boxer LM. (1997). J Biol Chem 272: 19609-19614.
15. Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang C et al. (2003a). Cancer Res 63: 6666-6673.
16. Heckman CA, Mehew JW, Boxer LM. (2002). Oncogene 21: 3898-3908.
17. Heckman CA, Mehew JW, Ying G-G, Introna M, Golay J, Boxer LM. (2000). J Biol Chem 275: 6499-6508.
18. Heckman CA, Wheeler MA, Boxer LM. (2003b). Oncogene 22: 7891-7899.
19. Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R et al. (2005). Blood 105: 3671-3678.
20. Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW et al. (2002). Blood 99: 282-289.
21. Inamoto S, Segil N, Pan ZQ, Kimura M, Roeder RG. (1997). J Biol Chem 272: 29852-29858.
22. Ji L, Mochon E, Arcinas M, Boxer LM. (1996). J Biol Chem 271: 22687-22691.
23. Jin T, Li H. (2001). J Biol Chem 276: 14752-14758.
24. Kang SM, Tsang W, Doll S, Scherle P, Ko HS, Tran AC et al. (1992). Mol Cell Biol 12: 3149-3154.
25. Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M et al. (1996). Nature 383: 542-547.
26. Kim U, Siegel R, Ren X, Gunther CS, Gaasterland T, Roeder RG. (2003). Proc Natl Acad Sci USA 100: 8868-8873.
27. LeBowitz JH, Clerc RG, Brenowitz M, Sharp PA. (1989). Genes Dev 3: 1625-1638.
28. Lossos IS, Levy R. (2000). Blood 96: 635-639.
29. Marafioti T, Ascani S, Pulford K, Sabattini E, Piccioli M, Jones M et al. (2003). Am J Pathol 162: 861-871.
30. McDonnell TJ, Korsmeyer SJ. (1991). Nature 349: 254-256.
31. Meeker T, Lowder J, Maloney DG, Miller R, Thielemans K, Warnke R et al. (1985). Blood 65: 1349-1354.
32. Miller CL, Feldhaus AL, Rooney JW, Rhodes LD, Sibley CH, Singh H. (1991). Mol Cell Biol 11: 4885-4894.
33. Nagy M, Chapuis B, Matthes T. (2002). Br J Haematol 116: 429-435.
34. Nielsen PJ, Georgiev O, Lorenz B, Schaffner W. (1996). Eur J Immunol 26: 3214-3218.
35. Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E et al. (2003a). Am J Pathol 162: 243-253.
36. Pileri SA, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E et al. (2003b). Leuk Lymphoma 44: S21-S26.
37. Poellinger L, Roeder RG. (1989). Mol Cell Biol 9: 747-756.
38. Robetorye RS, Bohling SD, Morgan JW, Fillmore GC, Lim MS, Elenitoba-Johnson KS. (2002). J Mol Diagn 4: 123-136.
39. Romero F, Martinez AC, Camonis J, Rebollo A. (1999). EMBO J 18: 3419-3430.
40. Sauter P, Matthias P. (1997). Immunobiology 198: 207-216.
41. Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P. (1996). Nature 383: 538-542.
42. Schubart K, Massa S, Schubart D, Corcoran LM, Rolink AG, Matthias P. (2001). Nat Immunol 2: 69-74.
43. Sepulveda MA, Emelyanov AV, Birshtein BK. (2004). J Immunol 172: 1054-1064.
44. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P et al. (1988). EMBO J 7: 123-131.
45. Staudt LM, Clerc RG, Singh H, LeBowitz JH, Sharp PA, Baltimore D. (1988). Science 241: 577-580.
46. Tanaka M, Herr W. (1990). Cell 60: 375-386.
47. Taylor D, Badiani P, Weston K. (1996). Genes Dev 10: 2732-2744.
48. Wang VE, Schmidt T, Chen J, Sharp PA, Tantin D. (2004). Mol Cell Biol 24: 1022-1032.
49. Wilson BE, Mochon E, Boxer LM. (1996). Mol Cell Biol 16: 5546-5556.
50. Wirth T, Priess A, Annweiler A, Zwilling S, Oeler B. (1991). Nucl Acids Res 19: 43-51.
51. Wong MW, Henry RW, Ma B, Kobayashi R, Klages N, Matthias P et al. (1998). Mol Cell Biol 18: 368-377.
52. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. (2001). Oncogene 20: 240-251.
53. Zwilling S, Dieckmann A, Pfisterer P, Angel P, Wirth T. (1997). Science 277: 193-194.